GLO1 and metabolic dysfunction-associated steatotic liver disease: MG-modified protein content of the liver was increased in HFD-fed rats [99] and in biopsies of patients with MASLD where increased MG was exacerbated by decreased glyoxalase 1 (Glo1) [100]—the major enzyme catalyzing the metabolism of MG [101].